Trial Profile
Examination of the symptom by a pharmacist performing continuously inhalational instruction for the Cough variant asthma patients who newly introduced Symbicort Tubuhaler
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 02 May 2019
Price :
$35
*
At a glance
- Drugs Budesonide/formoterol (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 28 Apr 2019 Status changed from not yet recruiting to discontinued.
- 02 Nov 2017 New trial record